Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients
- 1 August 2021
- journal article
- editorial
- Published by Elsevier in Journal of Hepatology
- Vol. 75 (2) , 265-266
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipientsJournal of Hepatology, 2021
- Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant RecipientsTransplantation, 2021
- Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virusAmerican Journal of Transplantation, 2021
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingNew England Journal of Medicine, 2021
- EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipientsJournal of Hepatology, 2021
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trialNature Medicine, 2020
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responsesNature, 2020
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity OutcomesJAMA, 2020
- Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practiceClinical Transplantation, 2019
- Serologic Vaccination Response after Solid Organ Transplantation: A Systematic ReviewPLOS ONE, 2013